FDA's General and Plastic Surgery Devices Panel stresses breast implant safety, importance of the NBIR, and patient engagement during March 25-26 hearingMarch 27
In both invited testimony and during open public comment periods, the FDA's General and Plastic Surgery Devices Panel heard from nearly 40 ASPS member surgeons on Monday and Tuesday.
- Planning the key to highly complicated – and successful – face transplant March 3
- The PSF past president helps young author find 'A Brave Face' March 2
- A young mother's view: Residency, reproduction and refrigerators March 1
- Strengthening a support network for plastic surgeons starting a family March 1